Table 4.

Mean symptom, sign, and total scores (SD) of 103 patients during the study

	AZT	AZT and DOXY	DOXY	DOXY and AZT	P
Pretreatment signs	11.6 (1.6)	N/A	10.9 (0.9)	N/A	>0.005
Symptoms	12 (1.4)	N/A	11,4 (1.7)	N/A
Total	23.6 (2.1)	N/A	22.3 (2)	N/A
First control signs	7.5 (1.4)	N/A	7.4 (1.2)	N/A	>0.005
Symptoms	5 (0)	N/A	4.6 (1.5)	N/A
Total	12.5 (1.4)	N/A	12 (1.8)	N/A
Second control signs	5.3 (1.2)	N/A	6.8 (0.6)	N/A	>0.005
Symptoms	5.9 (0.3)	N/A	4.5 (1.5)	N/A
Total	11.2 (1.3)	N/A	11.3 (1.1)	N/A
Third control signs	5.5 (1.3)	6.6 (1.3)	6.3 (0.5)	7.7 (1.5)	<0.005*
Symptoms	4.8 (0.4)	5 (0)	4.5 (1.5)	5.6 (1.5)
Total	10.3 (1.5)	11.6 (1.3)	10.8 (1.2)	13.4 (2)
Fourth follow-up signs	5.6 (1.4)	6.3 (1.5)	6.8 (0.8)	7.5 (1.3)	<0.005*
Symptoms	4.4 (0.8)	4.4 (0.5)	4.5 (1.4)	5.6 (1.4)
Total	10 (1.5)	10.7 (1.6)	11.3 (1.6)	13.1 (1.9)

SD: Standard deviation; AZT: Azythromicin; DOXY: Doxycycline; *Statistical significance